10x Genomics Partners with Anthropic to Bring AI-Powered Single Cell Analysis to Scientists
Reuters
Oct 21, 2025
10x Genomics Partners with Anthropic to Bring AI-Powered Single Cell Analysis to Scientists
10x Genomics Inc. has announced a collaboration with Anthropic, the AI safety and research company behind Claude, to make single cell and spatial biology analysis more accessible to scientists. By integrating 10x's advanced analysis tools into the newly launched Claude for Life Sciences platform, the partnership allows researchers to interact with complex datasets using natural language rather than code. This initiative aims to lower technical barriers, enabling a broader range of scientists to perform tasks such as data alignment, clustering, and interpretation through a conversational interface, ultimately accelerating discovery and innovation in biological research.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA01338) on October 20, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.